News
Rising payment rate for branded medicines exposes ‘fundamentally broken’ UK market – ABPI
The Department of Health and Social Care (DHSC) has proposed to raise the Statutory Scheme payment rate for newer branded medicines from 15.5% to 32.2% in the second half of 2025.
Mar 17, 2025







